Page 2 - Nikita Vashisht

Brokerages bullish on M&M on SUV growth, product pipeline; flag margin risk

M&M Q4 results analysis: Brokerages stay bullish on M&M amid strong SUV growth and earnings outlook. They see up to 43 per cent upside in M&M share price despite margin pressure, tractor sales' risks

Bank of Baroda Q4 preview: Profit, NII seen weak despite strong loan growth

Bank of Baroda Q4FY26 results preview: Profit may remain flat or decline as treasury losses, NIM pressure offset strong loan growth. Check estimates, dividend outlook.

SBI Q4 results preview: Profit may drop up to 12% on treasury loss

SBI Q4FY26 preview: Profit may fall up to 12% due to weak treasury income. Brokerages share NII, loan growth, NIM and dividend expectations

High oil prices, weak rupee: 5 reasons why Sensex fell 750 points intraday

Stock market crash today: Sensex drops 750 pts, Nifty falls below 24,000 intraday as renewed US-Iran tensions, crude oil above $110, weak rupee, and FII selling drag markets on May 5

Vedanta demerger: How the five-way split may solve debt concerns

Vedanta's five-way demerger is seen reducing debt, improving leverage and unlocking value across businesses, with stronger balance sheet visibility ahead

We used the March stock market crash to deploy funds: Kashyap Javeri

India Inc's Q4FY26 earnings have largely met expectations, supported by steady demand trends. However, rising commodity prices and geopolitical risks could pressure margins in coming quarters.

Oil above $100, Iran war drags: Should investors 'Sell in May' or stay put?

Is "Sell in May" relevant for India? Analysts say no as earnings strength, valuations, and April's rally support staying invested despite high crude oil prices and Iran war risks

Waaree Energies plunges 10% after Q4 miss; Ebitda margin shrinks to 18.6%

Waaree Energies shares fell 10.9 per cent after Q4FY26 margin miss. Ebitda margin dropped to 18.6 per cent despite strong revenue and profit growth

Rupee hits record low: Analysts flag 96-97 levels as oil, Fed stance weigh

Rupee hit a record low of 95.32 vs dollar on Thursday. Going ahead, analysts see further downside with 96-97 levels in focus as oil surge, FII outflows and hawkish US Fed weigh on outlook

Eternal stock: Strong guidance aids outlook; Street sees up to 58% upside

Eternal delivered steady Q4 results, with Blinkit and food delivery businesses driving growth. Brokerages have retained a 'Buy' rating with target prices up to ₹400

Iran war completes 2 months: Nifty targets cut amid oil, inflation risks

Brokerages have cut Nifty targets by around 4% per cent since February 28 as Iran war keeps oil prices high, raising inflation, GDP, and earnings concerns for Indian stock markets

UltraTech Cement delivers a Q4 beat; cost pressures keep analysts wary

UltraTech Cement posts strong Q4FY26 results, but analysts stay cautious due to cost pressures, capacity expansion risks, and sector headwinds

Varun Beverages shares rise 2% on Q1 beat; Brokerages raise target prices

VBL shares rose in trade on Tuesday after the company posted strong Q1CY26 results. Emkay Global, MOFSL, and Elara have raised target prices on margin strength, demand outlook, and expansion plans

'What investors should do now depends more on temperament than market view'

Markets are reasonable but not cheap: Kalpen Parekh of DSP Mutual Fund flags risks from geopolitics, flows, and inflation; urges disciplined investing

5 reasons why Goldman Sachs is bullish on Indian steel stocks

Goldman Sachs has initiated coverage of Indian metal (steel) stocks as itsees India as the next steel demand driver. It is bullish on Tata Steel, JSW Steel, Shyam Metalics among others

Axis Bank shares fall 5% despite positive outlook; should investors buy?

Axis Bank shares fell nearly 5 per cent today even as brokerages raised target prices post Q4 results, citing strong loan growth. They, however, flagged NIM pressure and soft core earnings

Cipla gains US FDA nod for Ventolin; analysts see $100 mn sales potential

Cipla has received the US FDA's approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook

IKS Health shares jump 9% on TruBridge acquisition; deal seen EPS accretive

IKS Health shares surged 9.5 per cent after announcing a $557-million TruBridge acquisition. The deal, it said, will boost EPS outlook, add EHR SaaS, and unlock $575-million cross-sell potential

Emkay downgrades OMCs as oil prices surge; FY27 earnings may fall up to 60%

Emkay Global has cut ratings on OMC stocks as rising crude and windfall tax may hit margins. The brokerage sees up to 60% decline in FY27 earnings for HPCL, BPCL, IOCL

Iran war opens opportunities in renewable, CGD cos, but risks remain: Kotak

Iran war-led energy crisis may boost shift to renewable energy sources. Kotak Institutional Equities sees growth for CGD companies but warns of valuation, margin and demand risks